皮膚科5 篇

影響力 2

Distinct ocular safety profiles of dupilumab and upadacitinib in atopic dermatitis: a real-world study with ophthalmological and microbiological assessment.

發表日期: 2026-12-01

The Journal of dermatological treatment

MediLens 收錄日: 2026-05-10

This study compares ocular outcomes and conjunctival microbiology in patients with moderate-to-severe atopic dermatitis treated with dupilumab versus upadacitinib. The results indicate that while both treatments have comparable dermatological efficacy, dupilumab is linked to a higher incidence of...

在PubMed上閱讀

影響力 2

Sentinel lymph node detection in melanoma: indocyanine green fluorescence compared with conventional mapping techniques.

發表日期: 2026-05-11

Melanoma research

MediLens 收錄日: 2026-05-12

This review evaluates the efficacy of near-infrared fluorescence with indocyanine green (ICG) compared to conventional sentinel lymph node (SLN) mapping techniques using technetium-99m (Tc-99m) and blue dye in melanoma staging. ICG demonstrates high identification rates (≈79-100%) and is superior...

在PubMed上閱讀

影響力 2

Novel uveal melanoma patient-derived cell line and organoid models show increased treatment resistance compared with commercially available cell lines.

發表日期: 2026-05-11

Melanoma research

MediLens 收錄日: 2026-05-12

This study compares the drug responses of uveal melanoma patient-derived cell lines (PDLs) and patient-derived organoids (PDOs) with commercially available cell lines, contextualizing laboratory results with clinical trial outcomes. The results indicate that while commercial cell lines showed a v...

在PubMed上閱讀

影響力 1

Report From the International Conference on Incontinentia Pigmenti: Translating Discovery to Therapy.

發表日期: 2026-05-11

American journal of medical genetics. Part A

MediLens 收錄日: 2026-05-12

Incontinentia pigmenti (IP) is a rare X-linked dominant condition with significant CNS and ophthalmic manifestations that can lead to neurologic impairment and vision loss. A conference was held to address the limited understanding of IP and to provide recommendations for screening and management...

在PubMed上閱讀

影響力 1

Spesolimab for Generalized Pustular Psoriasis in the Late Second Trimester of Pregnancy.

發表日期: 2026-05-11

The Journal of dermatology

MediLens 收錄日: 2026-05-12

(No abstract provided)

在PubMed上閱讀

醫學研究趨勢

皮膚科5 篇

Distinct ocular safety profiles of dupilumab and upadacitinib in atopic dermatitis: a real-world study with ophthalmological and microbiological assessment.

Sentinel lymph node detection in melanoma: indocyanine green fluorescence compared with conventional mapping techniques.

Novel uveal melanoma patient-derived cell line and organoid models show increased treatment resistance compared with commercially available cell lines.

Report From the International Conference on Incontinentia Pigmenti: Translating Discovery to Therapy.

Spesolimab for Generalized Pustular Psoriasis in the Late Second Trimester of Pregnancy.

獲取個人化每日摘要